- Home
- GURE vs SNSE Comparison
GURE vs SNSE Comparison
Compare GURE & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- SNSE
- Stock Information
- Founded
- GURE 2006
- SNSE 2005
- Country
- GURE China
- SNSE United States
- Employees
- GURE N/A
- SNSE N/A
- Industry
- GURE Major Chemicals
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- SNSE Health Care
- Exchange
- GURE Nasdaq
- SNSE Nasdaq
- Market Cap
- GURE 9.5M
- SNSE 10.5M
- IPO Year
- GURE 1992
- SNSE 2021
- Fundamental
- Price
- GURE $0.75
- SNSE $8.32
- Analyst Decision
- GURE
- SNSE Strong Buy
- Analyst Count
- GURE 0
- SNSE 4
- Target Price
- GURE N/A
- SNSE $72.50
- AVG Volume (30 Days)
- GURE 60.5K
- SNSE 16.5K
- Earning Date
- GURE 08-13-2025
- SNSE 08-05-2025
- Dividend Yield
- GURE N/A
- SNSE N/A
- EPS Growth
- GURE N/A
- SNSE N/A
- EPS
- GURE N/A
- SNSE N/A
- Revenue
- GURE $13,919,011.00
- SNSE N/A
- Revenue This Year
- GURE N/A
- SNSE N/A
- Revenue Next Year
- GURE N/A
- SNSE N/A
- P/E Ratio
- GURE N/A
- SNSE N/A
- Revenue Growth
- GURE N/A
- SNSE N/A
- 52 Week Low
- GURE $0.50
- SNSE $5.00
- 52 Week High
- GURE $1.47
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- GURE 60.43
- SNSE 52.54
- Support Level
- GURE $0.69
- SNSE $7.79
- Resistance Level
- GURE $0.75
- SNSE $9.08
- Average True Range (ATR)
- GURE 0.07
- SNSE 0.63
- MACD
- GURE 0.00
- SNSE 0.06
- Stochastic Oscillator
- GURE 56.25
- SNSE 59.39
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).